Abdulla Azizov, Director of the Agency of Uzbekistan for the Development of the Medical and Pharmaceutical Industry, held a meeting with Ramesh Juney, Chairman of one of India's largest pharmaceutical companies, Mankind Pharma, during an official visit to India.
The parties discussed the potential for implementing investment projects and expanding cooperation in Uzbekistan's pharmaceutical sector. The main focus was on the production of modern medicines, the development of research and development (R&D) activities and innovations, technology transfer, as well as the creation of high-tech production facilities with high added value.
Representatives of Mankind Pharma were presented with the concept of the BioPharma City pharmaceutical cluster. The presentation covered the project's opportunities, conditions for foreign investors, and tax and customs benefits available for investment initiatives.
The company's management positively assessed the conditions created for the development of Uzbekistan's pharmaceutical industry and expressed interest in jointly studying specific areas for investment partnership and the implementation of promising projects.
Mankind Pharma, founded in 1995, is one of India's leading pharmaceutical companies. It produces prescription and over-the-counter medications, as well as consumer health products, exporting its products to more than 70 countries.
During the working visit of the Director of the Pharmaceutical Industry Development Agency, Abdulla Azizov, to India, Uzbekistan and India discussed opportunities to deepen interaction in the field of pharmaceuticals.
The meeting took place with India's Minister of Trade and Industry, Piyush Goyal, as part of the Uzbek delegation led by the Minister of Investment, Industry and Trade, Laziz Kudratov.
The parties reviewed issues of further development of trade, economic, and investment cooperation, as well as increasing bilateral trade turnover, expanding industrial partnership, and supporting joint investment projects.
The negotiators paid special attention to interaction in the pharmaceutical field. They discussed prospects for joint production of medicines and medical devices, technology transfer, scientific research, implementation of innovative developments, and realization of high value-added projects.
At the end of the meeting, the parties reaffirmed their commitment to strengthening the strategic partnership between Uzbekistan and India, expanding business contacts, and continuing joint work on promising projects.
Representatives of state bodies and business circles from Uzbekistan and Kyrgyzstan discussed opportunities for partnership in the field of pharmaceuticals, industrial cooperation, and joint investment projects. The event took place as part of the Uzbekistan-Kyrgyzstan Business Forum held in Bishkek.
A panel session dedicated to healthcare and pharmaceuticals was organized within this forum. During the session, a representative of the Agency for the Development of Medical and Pharmaceutical Industry of Uzbekistan presented information on the investment potential of the country's pharmaceutical sector.
Forum participants received information about current investment projects being implemented in Uzbekistan, as well as about state support measures, the investment climate, and opportunities provided by free economic zones. Furthermore, reforms aimed at developing the pharmaceutical industry were presented.
During the discussion, the parties also exchanged views on expanding cooperation between Uzbekistan and Kyrgyzstan in the field of drug production, technology transfer, and the implementation of joint initiatives.
The Director of the Agency for the Development of the Medical and Pharmaceutical Sector, Abdulla Azizov, held a meeting with representatives of IQVIA. The goal of the negotiations was to discuss the current state of the pharmaceutical market in Uzbekistan and potential areas for joint work in analytics and strategic development.
During the meeting, IQVIA representatives demonstrated the company's global activities, as well as modern data analysis solutions designed for the pharmaceutical and medical sectors, including capabilities for comprehensive market research.
Analytical materials concerning the pharmaceutical market of Uzbekistan were presented. Participants reviewed key indicators of domestic pharmaceutical enterprises, key market trends, growth dynamics in various therapeutic areas, and prospects for further sector development.
The parties also discussed the possibility of using international analytical information to increase the transparency and competitiveness of the pharmaceutical market. Furthermore, strengthening the investment attractiveness of the sector and expanding areas of cooperation were discussed.
Following the discussion, an agreement was reached to continue cooperation. This collaboration will focus on using modern data analysis and marketing research tools for decision-making, strategic development of the pharmaceutical industry, and expanding international partnerships.
